Regulatory & Compliance

A side of chips

Advances in the science of microfluidics have led to a whole raft of novel devices. But due to considerations like complexity and cost, many of the teams behind the devices have been unable to produce them at scale. What are the major barriers to commercialisation, and what can be done to overcome them? Abi Millar finds out from Nikolaj Gadegaard, professor of biomedical engineering at the University of Glasgow, and Henne van Heeren, owner of enablingMNT.


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Vist our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the Progressive Media network.